Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Cytek Biosciences Inc (CTKB)

Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference GlobeNewswire - Wed Nov 20, 3:05PM CST

CTKB : 6.32 (+2.10%)
Cytek Biosciences Named "Overall BioTech Company of the Year" in 2024 BioTech Breakthrough Awards Quiver Quantitative, Inc. - Wed Nov 20, 2:24AM CST

Cytek Biosciences received the "Overall BioTech Company of the Year" award for advancements in cell analysis technology.Quiver AI SummaryCytek Biosciences, Inc. has been awarded "Overall BioTech Company...

CTKB : 6.32 (+2.10%)
Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program GlobeNewswire - Tue Nov 19, 4:00PM CST

CTKB : 6.32 (+2.10%)
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter GlobeNewswire - Thu Nov 7, 4:00PM CST

CTKB : 6.32 (+2.10%)
Cytek Biosciences Reports Third Quarter 2024 Financial Results GlobeNewswire - Tue Nov 5, 3:05PM CST

CTKB : 6.32 (+2.10%)
Cytek Biosciences to Participate in Upcoming Investor Conferences GlobeNewswire - Wed Oct 30, 3:05PM CDT

CTKB : 6.32 (+2.10%)
Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024 GlobeNewswire - Tue Oct 29, 3:05PM CDT

CTKB : 6.32 (+2.10%)
Why Shares of Cytek Biosciences Dropped This Week Motley Fool - Fri May 12, 2023

Cytek grew revenue and losses in the first quarter.

CTKB : 6.32 (+2.10%)
Cytek Biosciences Set to Join S&P SmallCap 600 PR Newswire - Tue Apr 25, 2023

/PRNewswire/ -- Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P SmallCap 600 effective prior to the opening...

SPGI : 491.81 (+1.08%)
CTKB : 6.32 (+2.10%)
CSII : 20.00 (+0.15%)
ABT : 114.23 (+1.61%)
Cytek Biosciences Reports Second Quarter 2022 Financial Results Globe Newswire - Wed Aug 10, 2022

Second quarter revenue grew 32% compared to prior year...

CTKB : 6.32 (+2.10%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot